⚠️ Unsupported Browser

Your browser is not supported.

The latest version of Safari, Chrome, Firefox, Internet Explorer or Microsoft Edge is required to use this website.

Click the button below to update and we look forward to seeing you soon.

Update now

Why Key Account Excellence can no longer be just an aspiration

Customer-centric capabilities 18th June 2020

For some time, pharma and biotech organisations have been practising Key Account Management and building towards Key Account Excellence (KAE). Following the recent and dramatic changes provoked by the pandemic  and our increasing realisation that we won’t be ‘going back’ to the old ways of thinking, working and engaging with customers, KAE can no longer be aspirational. KAE can now be seen as a foundation or platform for the next wave of capability development that is now necessary. 

Our data and work with clients on how to emerge from the crisis well, suggests that for customer relationships to thrive, pharma and biotech must work on building a new suite of future-focused capabilities – firmly establish consistent Key Account Excellence and move rapidly towards becoming an account-first organisation. 

This downloadable resource offers an overview of these new areas of focus.

Complete the form to download this resource